Compstatin analog Cp40 inhibits complement dysregulation in vitro in C3 glomerulopathy

C3 glomerulopathy: consensus report

Matthew C. Pickering, Vivette D. D’Agati, Carla Nester et al. · Kidney International · 2013 · 641 citations · Full text

Medicine, Nephrology, Pathology +17

Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies

Aude Servais, Laure‐Hélène Noël, Lubka T. Roumenina et al. · Kidney International · 2012 · 567 citations

Medicine, Immunology, Nephrology +17

Long‐term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal haemoglobinuria

Peter Hillmen, Petra Muus, Alexander Röth et al. · British Journal of Haematology · 2013 · 387 citations · Full text

Medicine, Hematology, Pharmacology +17

Eculizumab for Dense Deposit Disease and C3 Glomerulonephritis

Andrew S. Bomback, Richard J. Smith, Gaetano R. Barile et al. · Clinical Journal of the American Society of Nephrology · 2012 · 362 citations

Medicine, Immunology, Nephrology +17

Serum C′3 Lytic System in Patients with Glomerulonephritis

Roxane Spitzer, Enrique H. Vallota, J Forristal et al. · Science · 1969 · 261 citations

Medicine, Immunology, Nephrology +17